SEM cross-section images of implants after drug release for 30 days.

UNC researchers have created an injectable multi-drug delivery system that is removable, biodegradable and effective for up to a year in some cases. First author Rahima Benhabbour, PhD, MSc, says the ability to administer multiple drugs with this implant is an important advancement in this research.

The late Kevin R. Robertson, PhD, professor of neurology and director of neuropsychology, was co-lead author of the study.

A new study finds that nearly half of cells sampled from the cerebrospinal fluid of HIV patients had viral DNA, even though the patients had been on antiretroviral treatment for several years. The late Kevin R. Robertson, PhD, was co-lead author, and Joseph J. Eron, MD, is a co-author.

The “Carolinas United to End HIV (CUE-HIV)” partnership aims to decrease the number of HIV infections by 90 percent in ten years.

Led by J. Victor Garcia, PhD, UNC researchers report in the Journal of Clinical Investigation that T cells in the brain may be an important HIV reservoir that should be targeted by HIV cure approaches.

Tag: HIV/AIDS

Long-Acting Injectable Multi-Drug Implant Shows Promise for HIV Prevention and Treatment

HIV-infected cells persist in cerebrospinal fluid, linked to poorer neurocognitive performance

NC, SC Join Forces to Combat HIV Epidemic

T cells alone are sufficient to establish and maintain HIV infection in the brain